Victory Capital Management
RXST icon

Victory Capital Management’s RxSight RXST Stock Holding History

Victory Capital Management’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-281,658
Closed -$7.11M – 2544
2025
Q1 		$7.11M Buy
281,658
+9,680
+4% +$288K 0.01% 1175
2024
Q4 		$9.35M Buy
271,978
+12,114
+5% +$546K 0.01% 1105
2024
Q3 		$12.8M Buy
259,864
+45,161
+21% +$2.31M 0.01% 1011
2024
Q2 		$12.9M Buy
214,703
+38,349
+22% +$2.19M 0.01% 988
2024
Q1 		$9.1M Sell
176,354
-80,330
-31% -$3.94M 0.01% 1089
2023
Q4 		$10.3M Buy
256,684
+133,642
+109% +$3.92M 0.01% 1042
2023
Q3 		$3.43M Buy
+123,042
New +$3.67M ﹤0.01% 1278

Other funds holding RXST

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Victory Capital Management's RXST Position: Q2 2025 in Review

Victory Capital Management sold out of RxSight (RXST) in Q2 2025, closing a stake of 281,658 shares — an estimated $7.11M sold.

Victory Capital Management first reported a position in RXST in Q3 2023 and held it in 7 quarters. The position peaked at $12.9M in Q2 2024. 174 funds tracked by Wall St. Rank hold RXST as of Q2 2025.

  • Victory Capital Management reported no remaining RxSight position as of Q2 2025 after selling out during the quarter.
  • Victory Capital Management sold 281,658 RxSight shares in Q2 2025, an estimated $7.11M.
  • Victory Capital Management first reported a position in RxSight in Q3 2023 and held it in 7 quarters.
  • Victory Capital Management's RxSight position peaked at $12.9M in Q2 2024.
  • 174 funds tracked by Wall St. Rank held RxSight as of Q2 2025.

Based on Victory Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.